Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | HTT | P42858 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | MAOB | P27338 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 7/20 | 0.47 |
| ▸ | CA1 | P00915 | 6/20 | 0.47 |
| ▸ | CA2 | P00918 | 6/20 | 0.47 |
| ▸ | CA12 | O43570 | 6/20 | 0.47 |
| ▸ | RYR2 | Q92736 | 1/20 | 0.45 |
| ▸ | EGFR | P00533 | 1/20 | 0.45 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | METAP1 | P53582 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8118067 | 0.86 | RYR2 (0.56) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL67590 | 0.83 | KDM4E (1.00) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL6366190 | 0.80 | KDM4E (0.82) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL29853726 | 0.79 | CA12 (0.53) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL26768607 | 0.79 | CA12 (0.53) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL13871409 | 0.76 | EPHX2 (0.53) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL22451348 | 0.75 | KDM4E (0.56) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL31260280 | 0.75 | ALDH1A1 (0.57) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL1987343 | 0.75 | ALDH1A1 (0.57) | KDM4EHTTALDH1A1MAOAMAOB | |
| SCHEMBL31260278 | 0.75 | ALDH1A1 (0.57) | KDM4EHTTALDH1A1MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9211725-B2 | Inkjet recording method and printed material | FUJIFILM CORPORATION (JP) | 2015-12-15 | — | — | US | disclosed |
| EP-2682272-B1 | INK JET RECORDING METHOD AND PRINTED MATERIAL | FUJIFILM CORP (JP) | 2015-08-26 | — | — | EP | disclosed |
| US-8378002-B2 | Aqueous ink composition, aqueous ink composition for inkjet recording, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8378002-B2 | Aqueous ink composition, aqueous ink composition for inkjet recording, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| EP-1831207-B1 | AMINOPYRIMIDINE COMPOUNDS AS PLK INHIBITORS | AMGEN INC (US) | 2012-11-14 | — | — | EP | disclosed |
| US-8168263-B2 | Photo-curable composition, ink composition, and inkjet recording method using the ink composition | FUJIFILM CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8168263-B2 | Photo-curable composition, ink composition, and inkjet recording method using the ink composition | FUJIFILM CORPORATION (JP) | 2012-05-01 | — | — | US | disclosed |
| US-8147921-B2 | Ink set for inkjet recording and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8147921-B2 | Ink set for inkjet recording and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-04-03 | — | — | US | disclosed |
| US-8128843-B2 | Photocurable composition, photocurable ink composition, process for producing photocured material, and inkjet recording method | FUJIFILM CORPORATION (JP) | 2012-03-06 | — | — | US | disclosed |
| US-20080182031-A1 | Sensitizing dye, an alpha-aminoketone or acyl phosphine oxide polymerization initiator and an ethylenically unsaturated bond-containing polymerizable compound | FUJIFILM CORPORATION (JP) | 2008-07-31 | — | — | US | disclosed |
| EP-1944173-A1 | Ink composition and inkjet recording method using the same | FUJIFILM Corporation (JP) | 2008-07-16 | — | — | EP | disclosed |
| EP-1831207-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| US-20070185133-A1 | Aminopyrimidine compounds and methods of use | AMGEN, INC. (US) | 2007-08-09 | — | — | US | disclosed |
| WO-2006066172-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | AMGEN, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| US-20020086895-A1 | Methods of treating fungal infections | CHU WAI-LAM ALEX (US) | 2002-07-04 | — | — | US | disclosed |
| EP-1005338-A4 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA INC (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6307070-B1 | FUNGICIDES | PHYTERA, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1005338-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 2000-06-07 | — | — | EP | disclosed |
| WO-1999004789-A1 | SUBSTITUTED AURONE DERIVATIVES | PHYTERA, INC. (US) | 1999-02-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086895-A1 | Methods of treating fungal infections | COXFA4L2, DPM1, ERG28 | KDM4E 2808/4885HTT 4866/4885ALDH1A1 1149/4885 |
| US-20070185133-A1 | Aminopyrimidine compounds and methods of use | PLK1, TYMP, TK2 | KDM4E 1956/4885HTT 2363/4885ALDH1A1 1565/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.